As Cancer Takes Her Life, JFK Descendant Opposes Cousin's Health Policies
- JFK's granddaughter Tatiana Schlossberg revealed terminal AML diagnosis, criticizing cousin RFK Jr.'s cuts to mRNA vaccine research funding critical for cancer therapies. - RFK Jr.'s HHS nomination faces scrutiny as his anti-vaccine policies align with CDC's revised guidelines, raising concerns about public health trust and research equity. - OCRA's new policy center and interactive map aim to accelerate cancer research access, responding to Schlossberg's advocacy for equitable clinical trial resources.
Tatiana Schlossberg, the granddaughter of John F. Kennedy, shared in a heartfelt essay for The New Yorker that she has been diagnosed with terminal cancer, while also condemning her cousin Robert F. Kennedy Jr. for policy choices she believes endanger cancer patients. At 34, Schlossberg revealed she was found to have acute myeloid leukemia with an uncommon mutation in May 2024, shortly after her second child was born. She described undergoing chemotherapy, two stem cell transplants, and participating in clinical trials, and recounted a recent conversation with her doctor who told her, "he could keep me alive for a year, maybe"
Schlossberg's criticism is directed at RFK Jr., who has become a notable figure in health policy and was recently nominated by President Donald Trump for Health and Human Services secretary. She called attention to RFK Jr.'s move to eliminate nearly $500 million in federal support for mRNA vaccine research—a technology she believes could be adapted to treat some cancers
This dispute highlights larger issues in American health policy, especially regarding funding for research and regulatory choices. The Ovarian Cancer Research Alliance (OCRA), which has long advocated for more federal funding, has recently established a Center for Public Policy to strengthen its advocacy. The center’s mission is to speed up research, broaden access to clinical trials, and enhance drug availability, echoing Schlossberg’s concerns about how resources are distributed
RFK Jr.'s role in shaping public health policy has also led to changes in vaccine recommendations. The CDC has recently updated its guidance on childhood vaccinations, moving away from universal recommendations for all age groups and instead encouraging more personalized discussions
Schlossberg’s openness about her diagnosis has reignited discussions about how politics and healthcare intersect. "For my whole life, I have tried to be good," she reflected, noting that her illness has brought "a new tragedy" to her family
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Animoca Receives ADGM Authorization, Opening a Regulated Avenue for Institutional Web3 Investments
- Animoca Brands secures in-principle approval from ADGM to operate as a regulated fund manager, advancing its institutional Web3 investment strategy in the Middle East. - The conditional approval enables compliance-focused expansion, aligning with UAE's blockchain innovation goals and institutional-grade investment pathways in gaming, NFTs, and tokenized assets. - With stakes in 600+ Web3 ventures, Animoca plans to integrate its ecosystem into regulated structures, complementing its $1B valuation target v
Dogecoin Latest Updates: Crypto Winter Challenges DOGE ETFs While Technical Indicators Suggest a Potential 80% Surge
- Dogecoin (DOGE) could surge 80-90% as ETF launches approach, driven by a falling wedge pattern and institutional interest in Grayscale's GDOG and 21Shares' products. - Technical analysts compare DOGE's potential to XRP's 2025 ETF-driven rally, though broader crypto weakness and high interest rates pose risks to sustained gains. - While DOGE trades below key moving averages and faces $0.1495 resistance, a breakout above the wedge's trendline could push prices toward $0.27–$0.29. - Long-term projections su
Bitcoin Updates: Crypto ETPs Signal Market Growth as Leverage Shares Debuts on SIX
- Leverage Shares launched the world's first 3x leveraged and -3x inverse Bitcoin/Ethereum ETPs on SIX Swiss Exchange, expanding its crypto product range to 452 offerings. - The EUR/USD-traded ETPs target sophisticated investors seeking directional exposure, aligning with SIX's 19% YoY crypto ETP turnover growth to CHF 3.83 billion. - Market timing raises concerns as Bitcoin/Ethereum fell 21%/26% in November 2025, with experts warning leveraged products could amplify losses during volatility. - SIX's regul
Ethereum Updates Today: Buterin Moves ETH to Safeguard Privacy Against Major Financial Players and Quantum Threats
- Ethereum co-founder Vitalik Buterin donated 128 ETH ($760,000) to privacy-focused apps Session and SimpleX Chat, emphasizing decentralized metadata protection and user-friendly access. - Recent 1,009 ETH transfer to Railgun protocol sparked speculation about asset reallocation, though control remains with Buterin amid mixed Ethereum price trends. - Buterin warns of existential risks: 10.4% institutional Ether ownership and quantum computing threats by 2028, advocating layered security for Ethereum's desi
Trending news
MoreCrypto prices
More
